Concepedia

Fariba Soleymanzadeh

FS

Statistics

Publications

8

Citations

298

H-Index

8

Active since

2000

Affiliations

Boehringer Ingelheim (United States)(Current)

Boehringer Ingelheim (France)

Fariba Soleymanzadeh is an author at Boehringer Ingelheim (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

2000–2012

8

Publications

8

Structure-Based Optimization of Arylamides as Inhibitors of Soluble Epoxide Hydrolase

Anne B. Eldrup, Fariba Soleymanzadeh, Steven J. Taylor et al. · Journal of Medicinal Chemistry · 2009 · 69 citations · Full text

, , +17

Synthesis of Stereodefined Polysubstituted Olefins. 1. Sequential Intermolecular Reactions Involving Selective, Stepwise Insertion of Pd(0) into Allylic and Vinylic Halide Bonds. The Stereoselective Synthesis of Disubstituted Olefins<sup>1</sup>

Michael G. Organ, Jeremy T. Cooper, Lawrence R. Rogers et al. · The Journal of Organic Chemistry · 2000 · 61 citations

Identification of a Potent Sodium Hydrogen Exchanger Isoform 1 (NHE1) Inhibitor with a Suitable Profile for Chronic Dosing and Demonstrated Cardioprotective Effects in a Preclinical Model of Myocardial Infarction in the Rat

John D. Huber, Jörg Bentzien, Stephen J. Boyer et al. · Journal of Medicinal Chemistry · 2012 · 34 citations · Full text

, , +15

Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase

Anne B. Eldrup, Fariba Soleymanzadeh, Neil A. Farrow et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 33 citations · Full text

, , +3

Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design

Brian N. Cook, Jörg Bentzien, André White et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 33 citations · Full text

, , +11

Rows per page

1–5 of 8